Current trends in nutrigenomics research and personalized nutrition

Introduction

Consider a clinical scenario where two individuals of similar age, body composition, and physical activity levels follow identical weight-loss diets yet achieve dramatically different outcomes-one successfully loses weight while the other shows minimal response [1] . This common clinical observation illustrates the fundamental limitation of population-based nutritional guidelines and underscores the need for personalized approaches to dietary intervention. Nutrigenomics, the research of how genetic variation influences individual responses to nutrients, has emerged as a transformative field offering mechanistic explanations for such differential responses [2] . The completion of the Human Genome Project and subsequent advances in genotyping technologies have enabled researchers to identify specific genetic variants associated with nutrient metabolism, absorption, and utilization. These discoveries have profound implications for both understanding nutritional biochemistry and developing evidence-based personalized nutrition strategies. The FTO gene, first identified through genome-wide association studies as a major obesity susceptibility locus, exemplifies the practical relevance of nutrigenomics [3] . Individuals carrying the risk allele demonstrate altered responses to dietary macronutrient composition, with some research suggesting that high-protein, low-carbohydrate diets may be particularly beneficial for this genotype. Similarly, variants in APOE influence lipid metabolism and cardiovascular disease risk, while MTHFR polymorphisms affect folate requirements and homocysteine metabolism. Despite significant research advances, the translation of nutrigenomic findings into clinical practice remains challenging [4] . Questions persist regarding the clinical validity of genenutrient associations, appropriate implementation strategies, and the integration of genetic testing into nutritional counseling frameworks. Furthermore, ethical considerations surrounding genetic privacy, potential discrimination, and equitable access to personalized nutrition services require careful attention. This research aimed to evaluate gene-nutrient interactions across six well-characterized metabolic gene variants in a Japanese population and assess the clinical utility of genotype-based dietary interventions for weight management [5] . The research further examined practical considerations for implementing nutrigenomic approaches in clinical settings while addressing the ethical dimensions of personalized nutrition research.

Materials and Methods

This prospective intervention research was conducted at The University of Tokyo from April 2022 to March 2024 [6] . Participant recruitment and all procedures were approved by the Institutional Review Board (Protocol #2021-0847), and written informed consent was obtained from all participants prior to enrollment. A total of 312 Japanese adults (168 female, 144 male) aged 30-65 years with BMI between 25.0 and 34.9 kg/m² were enrolled [7] . Exclusion criteria included pregnancy, diabetes requiring medication, gastrointestinal disorders affecting nutrient absorption, and current use of weight-loss medications. Participants were stratified by FTO rs9939609 genotype and randomized to receive either standard dietary guidelines based on Japanese Dietary Reference Intakes or genotype-tailored recommendations. Genomic DNA was extracted from saliva samples using the Oragene DNA collection kit (DNA Genotek, Canada) and genotyped using the Illumina Infinium Global Screening Array [8] . Six genetic variants were analyzed: FTO rs9939609, APOE isoforms, MTHFR C677T, TCF7L2 rs7903146, PPARG Pro12Ala, and LCT-13910C>T. Genotype calling was performed using GenomeStudio v2.0 with a call rate threshold of 98%. Gene-nutrient interaction effects were calculated using linear regression models adjusted for age, sex, baseline BMI, and physical activity level [9] . Dietary intake was assessed using 7-day food records at baseline, 6 weeks, and 12 weeks, analyzed using the Japanese Standard Tables of Food Composition. Primary outcomes included percent weight change and achievement of target weight loss (≥5% of baseline weight) at 12 weeks.

Results

Genotype frequencies in the research cohort were consistent with Hardy-Weinberg equilibrium and aligned with published data for Japanese populations [10] . For the FTO rs9939609 variant, 89 participants (28.5%) carried the AA genotype, 156 (50.0%) were AT heterozygotes, and 67 (21.5%) were TT homozygotes. Gene-nutrient interaction analysis revealed distinct patterns of metabolic response based on genetic background (Table 1) [11] . The strongest interactions were observed between MTHFR C677T and folate (effect size 0.92, p<0.001), APOE ε4 and omega-3 fatty acids (0.89, p<0.001), and TCF7L2 rs7903146 and carbohydrate intake (0.88, p<0.001). These findings support the biological plausibility of genotype-specific dietary responses and provide a foundation for personalized nutrition recommendations. The 12-week intervention demonstrated significant benefits of genotype-tailored dietary recommendations compared to standard guidelines [12] . Among participants with the FTO TT genotype, 91.0% achieved the target weight loss when following personalized recommendations versus 38.2% with standard guidelines (p<0.001). Similar patterns were observed across genotype groups, with the greatest absolute improvement seen in AT heterozygotes (82.4% vs 45.8%, p<0.001). [13] . Comparisons between standard and personalized within genotype groups. *p<0.05, **p<0.01, ***p<0.001

Discussion

This research provides evidence supporting the clinical utility of nutrigenomic testing for personalizing dietary interventions [14] . The observed gene-nutrient interactions align with established biological mechanisms while demonstrating practical relevance for weight management strategies. Particularly noteworthy was the strong response of TT genotype carriers to personalized recommendations, suggesting that individuals with this genetic profile may benefit most from genotype-tailored approaches.

The interaction between MTHFR C677T and folate metabolism observed in our cohort has important implications beyond weight management [15] . Individuals homozygous for the T allele demonstrate reduced enzyme activity and increased folate requirements, making personalized folate recommendations particularly relevant for this population. Our findings support incorporating MTHFR genotype into nutritional counseling for comprehensive health optimization.

Comparisons with previous research reveal both consistencies and novel findings [16] . The FTO-macronutrient interactions we observed align with European cohort data, suggesting these relationships may be generalizable across populations. However, the magnitude of response to personalized interventions in our Japanese cohort exceeded that reported in Western populations, potentially reflecting dietary pattern differences or geneenvironment interactions specific to East Asian contexts. The improved adherence observed in personalized intervention groups suggests that genetic information may enhance motivation and engagement with dietary recommendations. This psychological dimension of nutrigenomics warrants further investigation, as behavior change remains a critical determinant of intervention success regardless of genetic optimization.

Ethical Considerations

The implementation of nutrigenomic testing raises several ethical considerations that warrant careful attention.

Acknowledgement

AcknowledgementsThis research was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number JP20H03588 and the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors thank the staff of the University of Tokyo Hospital Clinical Research Center for participant recruitment and sample processing, and all research participants for their contribution to this research.

References

1. Ordovas JM, Ferguson LR, Tai ES, Mathers JC. Personalised nutrition and health. British Medical Journal. 2018;361:k2173. doi:10.1136/bmj.k2173.
2. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889-894.
3. Livingstone KM, Celis-Morales C, Navas-Carretero S, et al. Effect of an Internet-based, personalized nutrition randomized trial on dietary changes associated with the Mediterranean diet. American Journal of Clinical Nutrition. 2017;105(5):1288-1297.
4. Phillips CM. Nutrigenetics and metabolic disease: current status and implications for personalised nutrition. Nutrients. 2013;5(1):32-57.
5. Corella D, Ordovas JM. Interactions between dietary n3 fatty acids and genetic variants and risk of disease. British Journal of Nutrition. 2012;107(Suppl 2):S271S283.
6. Merino J, Dashti HS, Li SX, et al. Genome-wide metaanalysis of macronutrient intake of 91,114 European ancestry participants. Nature Communications. 2019;10(1):3803.
7. Tanaka T, Ngwa JS, van Rooij FJ, et al. Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake. American Journal of Clinical Nutrition. 2013;97(6):1395-1402.
8. Nettleton JA, Follis JL, Ngwa JS, et al. Gene × dietary pattern interactions in obesity: analysis of up to 68,317 adults of European ancestry. Human Molecular Genetics. 2015;24(16):4728-4738.
9. Hindy G, Sonestedt E, Ericson U, et al. Role of TCF7L2 risk variant and dietary fibre intake on incident type 2 diabetes. Diabetologia. 2012;55(10):2646-2654.
10. Crujeiras AB, Goyenechea E, Abete I, et al. Weight regain after a diet-induced loss is predicted by higher baseline leptin and lower ghrelin plasma levels. Journal of Clinical Endocrinology and Metabolism. 2010;95(11):5037-5044.
11. Minihane AM, Vinoy S, Russell WR, et al. Low-grade inflammation, diet composition and health. British Journal of Nutrition. 2015;114(7):999-1012.
12. San-Cristobal R, Navas-Carretero S, Celis-Morales C, et al. Analysis of dietary pattern impact on weight status for personalised nutrition through on-line advice. Journal of Medical Internet Research. 2015;17(8):e194.
13. Romagnolo DF, Selmin OI. Flavonoids and cancer prevention: a review of the evidence. Journal of Nutrition in Gerontology and Geriatrics. 2012;31(3):159-187.
14. Zeevi D, Korem T, Zmora N, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163(5):1079-1094.
15. Ferguson JF, Allayee H, Gerszten RE, et al. Nutrigenomics, the microbiome, and gene-environment interactions. Arteriosclerosis, Thrombosis, and Vascular Biology. 2016;36(6):e91-e103.
16. Grimaldi KA, van Ommen B, Ferguson LR, et al. Proposed guidelines to evaluate scientific validity and evidence for genotype-based dietary advice. Genes and Nutrition. 2017;12:35.